Drug Approval | August 20, 2024
Granules India receives ANDA approval for Glycopyrrolate Oral Solution
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
Glycopyrrolate Oral Solution is an anticholinergic medication indicated for pediatric patients
This marks the first regulatory approval worldwide for nasally-delivered epinephrine
Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC) is indicated to relieve redness of the eye due to minor eye irritations.
These results add to the growing body of evidence indicating a single dose of ABRYSVO provides strong immune protection against outcomes caused by RSV
Trazodone tablets are indicated for the treatment of major depressive disorder in adults
This strong performance was primarily on account of a one-time gain from the strategic collaboration between Biocon Biologics and Eris Lifesciences.
The drugmaker's net profit slipped 26 per cent on-year to Rs 143.8 crore
The successful completion of the global Phase 3 trials paves the way to obtain marketing approval in the U.S. and EU
Being the first approved applicant, Lupin is eligible for 180 days of CGT exclusivity
This product will be manufactured at Lupin’s Nagpur facility in India and will be supplied to low and middle-income countries
Subscribe To Our Newsletter & Stay Updated
